Cystic fibrosis: genes and variants
Explore variant evidence for Cystic fibrosis across 1 analyzed protein (CFTR). Linked ClinVar records include 156 pathogenic or likely pathogenic variants, 1,308 variants of uncertain significance and 128 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Cystic fibrosis
CFTR: Cystic fibrosis transmembrane conductance regulator
An epithelial chloride channel and regulator of salt and water movement across cell surfaces. Its activity helps keep airway, intestinal, and other epithelial fluids balanced, while CFTR disruption causes cystic fibrosis and related disorders.
156 ClinVar pathogenic / likely pathogenic and 1,433 uncertain variants in CFTR have source records linked to Cystic fibrosis. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): PIK3CG, HFE and TSC2.
Where Cystic fibrosis variants cluster
- CFTR Extracellular (positions 99–122): 13 of 156 ClinVar pathogenic / likely pathogenic variants, 5.1× more than its size predicts (a length-based count, not a validated hotspot).
- CFTR ABC transporter 1 (positions 423–646): 43 of 156 ClinVar pathogenic / likely pathogenic variants, 1.8× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Cystic fibrosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CFTR L102R | 102 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR R117P | 117 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR R117H | 117 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR D192G | 192 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR Y563D | 563 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR Y569D | 569 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR I601F | 601 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR G628R | 628 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR W1098C | 1098 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR W1098R | 1098 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR S1159P | 1159 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR G1244E | 1244 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR R1283M | 1283 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR W57G | 57 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR R1070Q | 1070 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR R3W | 3 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR G27R | 27 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR Q98R | 98 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR P99L | 99 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR L165S | 165 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR F191V | 191 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR E193K | 193 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR H199Y | 199 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR P205S | 205 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR F508C | 508 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR S549R | 549 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR R560S | 560 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR S945L | 945 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR H1054D | 1054 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR S1159F | 1159 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR V1240G | 1240 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR G1249R | 1249 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR I1269N | 1269 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR L1335P | 1335 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR I1366N | 1366 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR M1V | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR E60K | 60 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR E116K | 116 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR Y161D | 161 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR G194R | 194 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR M1101R | 1101 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR P67L | 67 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR G126D | 126 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR L227R | 227 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR E474K | 474 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR H609R | 609 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR A613T | 613 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR L927P | 927 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR T1036N | 1036 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR L1077P | 1077 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR S1118F | 1118 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR S1251N | 1251 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR S13F | 13 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR L15P | 15 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| CFTR H139R | 139 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR V232D | 232 | ABC transmembrane type-1 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR L453S | 453 | ABC transporter 1 | Pathogenic / likely pathogenic (★★★) |
| CFTR G970R | 970 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR D979V | 979 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic (★★★) |
| CFTR L1324P | 1324 | ABC transporter 2 | Pathogenic / likely pathogenic (★★★) |
Showing 60 of 156.
Uncertain variants prioritized for review in Cystic fibrosis
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CFTR Q552K | 552 | ABC transporter 1 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; Q552P at the same position is pathogenic; REVEL 0.914 |
| CFTR D979A | 979 | ABC transmembrane type-1 2 | Conflicting reports (★) | +6: D979V at the same position is pathogenic; REVEL 0.990 |
| CFTR Y161C | 161 | ABC transmembrane type-1 1 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; Y161D at the same position is pathogenic; REVEL 0.969 |
| CFTR Y109N | 109 | ABC transmembrane type-1 1 | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; Y109H at the same position is pathogenic; REVEL 0.917 |
| CFTR P1021S | 1021 | ABC transmembrane type-1 2 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P1021T at the same position is pathogenic; REVEL 0.832 |
| CFTR W1282C | 1282 | ABC transporter 2 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; W1282R at the same position is pathogenic; REVEL 0.782 |
| CFTR I471F | 471 | ABC transporter 1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; I471V at the same position is pathogenic; REVEL 0.957 |
| CFTR F587I | 587 | ABC transporter 1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; F587S at the same position is pathogenic; REVEL 0.828 |
| CFTR P205L | 205 | ABC transmembrane type-1 1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P205S at the same position is pathogenic; REVEL 0.811 |
| CFTR R1283K | 1283 | ABC transporter 2 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; R1283M at the same position is pathogenic; REVEL 0.915 |
| CFTR A559S | 559 | ABC transporter 1 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; A559P at the same position is pathogenic; REVEL 0.919 |
| CFTR S13C | 13 | Cytoplasmic | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; S13F at the same position is pathogenic; REVEL 0.899 |
| CFTR E474G | 474 | ABC transporter 1 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; E474K at the same position is pathogenic; REVEL 0.944 |
| CFTR E474Q | 474 | ABC transporter 1 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; E474K at the same position is pathogenic; REVEL 0.847 |
| CFTR M952T | 952 | ABC transmembrane type-1 2 | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; M952I at the same position is pathogenic; REVEL 0.924 |
| CFTR V317G | 317 | ABC transmembrane type-1 1 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; V317E at the same position is pathogenic; REVEL 0.895 |
| CFTR A1067G | 1067 | ABC transmembrane type-1 2 | Uncertain | +6: 5 other pathogenic changes within 3 positions; A1067P at the same position is pathogenic; REVEL 0.899 |
| CFTR V317M | 317 | ABC transmembrane type-1 1 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; V317E at the same position is pathogenic; REVEL 0.817 |
| CFTR M952V | 952 | ABC transmembrane type-1 2 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; M952I at the same position is pathogenic; REVEL 0.921 |
| CFTR K503E | 503 | ABC transporter 1 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; K503R at the same position is pathogenic; REVEL 0.834 |
| CFTR V317A | 317 | ABC transmembrane type-1 1 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; V317E at the same position is pathogenic; REVEL 0.816 |
| CFTR I1366F | 1366 | ABC transporter 2 | Uncertain (★★) | +6: I1366N at the same position is pathogenic; REVEL 0.950 |
| CFTR M1137T | 1137 | ABC transmembrane type-1 2 | Uncertain | +6: 2 other pathogenic changes within 3 positions; M1137R at the same position is pathogenic; REVEL 0.908 |
| CFTR I1269M | 1269 | ABC transporter 2 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; I1269N at the same position is pathogenic; REVEL 0.794 |
Which prediction tools work for Cystic fibrosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 92 out of 100
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 87 out of 100
- AlphaMissense: 86 out of 100
- PolyPhen-2: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 83 out of 100
- SIFT: 80 out of 100
- phyloP: 75 out of 100
- Pangolin: 45 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 44 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Bronchiectasis with or without elevated sweat chloride 1 also has ClinVar records linked to CFTR variants; they fall in the same places as the Cystic fibrosis variants (18 pathogenic / likely pathogenic).
- Congenital bilateral aplasia of vas deferens from CFTR mutation also has ClinVar records linked to CFTR variants; they fall in the same places as the Cystic fibrosis variants (10 pathogenic / likely pathogenic).
- Hereditary pancreatitis also has ClinVar records linked to CFTR variants; they fall in the same places as the Cystic fibrosis variants (7 pathogenic / likely pathogenic).
Diseases related to Cystic fibrosis
- Bronchiectasis with or without elevated sweat chloride 1, also linked to CFTR
- Congenital bilateral aplasia of vas deferens from CFTR mutation, also linked to CFTR
- Hereditary pancreatitis, also linked to CFTR
- Ivacaftor response - Efficacy, also linked to CFTR
Frequently asked questions
Which genes have records linked to Cystic fibrosis?
This view contains 1 analyzed proteins: CFTR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 156 pathogenic or likely pathogenic variants, 1,308 variants of uncertain significance and 128 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 24 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,713 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center